15 results on '"Arch, Robert H"'
Search Results
2. Intratumoral delivery of immune therapy and gene therapy: the next era for cancer therapy.
- Author
-
Wu, Vincent M, Arch, Robert H, Canton, David A, and Zhang, Jun
- Published
- 2023
- Full Text
- View/download PDF
3. Function of tumor necrosis factor receptor family members on regulatory T-cells
- Author
-
Arch, Robert H.
- Published
- 2005
- Full Text
- View/download PDF
4. Inhibition of VEGFR-2 Reverses Type 1 Diabetes in NOD Mice by Abrogating Insulitis and Restoring Islet Function
- Author
-
Villalta, S. Armando, Lang, Jiena, Kubeck, Samantha, Kabre, Beniwende, Szot, Gregory L., Calderon, Boris, Wasserfall, Clive, Atkinson, Mark A., Brekken, Rolf A., Pullen, Nick, Arch, Robert H., and Bluestone, Jeffrey A.
- Published
- 2013
- Full Text
- View/download PDF
5. Anti-PDGF-B monoclonal antibody reduces liver fibrosis development
- Author
-
Ogawa, Shinji, Ochi, Takashi, Shimada, Hideaki, Inagaki, Kazuyuki, Fujita, Isami, Nii, Aisuke, Moffat, Mark A., Katragadda, Madan, Violand, Bernard N., Arch, Robert H., and Masferrer, Jaime L.
- Published
- 2010
- Full Text
- View/download PDF
6. Assessment of liver fibrosis progression and regression by a serological collagen turnover profile.
- Author
-
Karsdal, Morten A., Hjuler, Sara T., Yi Luo, Rasmussen, Daniel G. K., Nielsen, Mette J., Nielsen, Signe Holm, Leeming, Diana J., Goodman, Zachary, Arch, Robert H., Patel, Keyur, and Schuppan, Detlef
- Abstract
There is a need for noninvasive biomarkers that can identify patients with progressive liver fibrosis and monitor response to antifibrotic therapy. An equally important need is identification of patients with spontaneous fibrosis regression, since they may not need treatment nor be included in clinical studies with fibrosis as end point. Circulating biomarkers, originating from defined fragments of the scar tissue itself, may serve as valuable tools for this aspect of precision medicine. We investigated a panel of serological collagen formation and degradation markers to identify patients likely to regress or progress in absence of a therapeutic intervention. Plasma samples from patients with moderate-stage hepatitis C receiving placebo treatment in a phase II trial of the peroxisome proliferator-activated receptor agonist farglitazar were included. The patients had matched liver biopsies at baseline and 52 wk of follow-up. Serological biomarkers of collagen formation (PRO-C3, PRO-C4, PRO-C5) and collagen degradation (C3M, C4M, and C6M) were analyzed. Logistic regression analysis including PRO-C3 and C6M identified subjects with progressive liver fibrosis with an AUROC of 0.91 (P < 0.0001) and positive and negative predictive values (PPV/NPV) of 75.0%/88.6%. Low levels of PRO-C5 predicted a spontaneous regression phenotype, with an odds ratio of 33.8 times higher compared with patients with high levels (P < 0.0025) with an AUROC of 0.78 (P < 0.0001) and PPV/NPV of 60.0%/95.7%. Two collagen fragments (PRO-C3 and C6M) identified liver fibrosis progressors, and one collagen fragment (PRO-C5) identified liver fibrosis regressors. These biomarkers may improve patient stratification and monitor treatment efficacy in studies with fibrosis as clinical end point. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
7. Multiplex transcriptional analysis of paraffin-embedded liver needle biopsy from patients with liver fibrosis.
- Author
-
Staten, Nicholas R, Welsh, Eric A, Sidik, Kurex, McDonald, Sandra A, Dufield, Dawn R, Maqsodi, Botoul, Ma, Yunqing, McMaster, Gary K, Mathews, Rodney W, Arch, Robert H, Masferrer, Jaime L, and Souberbielle, Bernard E
- Subjects
LIVER cancer ,LIVER diseases ,NEEDLE biopsy ,GENE expression ,GENETIC regulation ,MESSENGER RNA - Abstract
Background: The possibility of extracting RNA and measuring RNA expression from paraffin sections can allow extensive investigations on stored paraffin samples obtained from diseased livers and could help with studies of the natural history of liver fibrosis and inflammation, and in particular, correlate basic mechanisms to clinical outcomes. Results: To address this issue, a pilot study of multiplex gene expression using branched-chain DNA technology was conducted to directly measure mRNA expression in formalin-fixed paraffin-embedded needle biopsy samples of human liver. Twenty-five genes were selected for evaluation based on evidence obtained from human fibrotic liver, a rat BDL model and in vitro cultures of immortalized human hepatic stellate cells. The expression levels of these 25 genes were then correlated with liver fibrosis and inflammation activity scores. Statistical analysis revealed that three genes (COL3A1, KRT18, and TUBB) could separate fibrotic from non-fibrotic samples and that the expression of ten genes (ANXA2, TIMP1, CTGF, COL4A1, KRT18, COL1A1, COL3A1, ACTA2, TGFB1, LOXL2) were positively correlated with the level of liver inflammation activity. Conclusion: This is the first report describing this multiplex technique for liver fibrosis and has provided the proof of concept of the suitability of RNA extracted from paraffin sections for investigating the modulation of a panel of proinflammatory and profibrogenic genes. This pilot study suggests that this technique will allow extensive investigations on paraffin samples from diseased livers and possibly from any other tissue. Using identical or other genes, this multiplex expression technique could be applied to samples obtained from extensive patient cohorts with stored paraffin samples in order to correlate gene expression with valuable clinically relevant information. This method could be used to provide a better understanding of the mechanisms of liver fibrosis and inflammation, its progression, and help development of new therapeutic approaches for this indication. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
8. LYMPHOCYTE SURVIVAL—THE STRUGGLE AGAINST DEATH.
- Author
-
Arch, Robert H. and Thompson, Craig B.
- Subjects
- *
CELL proliferation , *CELL death , *IMMUNE system , *CELLULAR signal transduction - Abstract
Cell proliferation and cell death must be closely regulated to maintain the integrity of the immune system during the lifetime of multicellular organisms. Proliferative expansion of lymphoid cells is required for effective immune responses against invading microorganisms. However, following infection eradication, expanded effector cells must be eliminated to prevent non-adaptive accumulation of cells. Therefore, higher vertebrates have developed an extensive network of signal transduction pathways that allow integration of cell survival and cell death stimuli. This network functions to ensure the controlled activation and expansion of cells during an immune response and the deletion of lymphoid cells that are no longer needed at the end of an immune response. Extracellular signals appear to control both mechanisms. Ultimate responses are integrated through cell surface receptors that are linked to intracellular signaling cascades. These signal transduction pathways converge to regulate cell fate at both transcriptional and post-transcriptional levels. In this review, the role of pathways triggered by TNFR-related molecules that determine the fate of lymphoid cells during development and activation is summarized. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
9. Tumor Necrosis Factor Receptor (TNFR)-associated Factor 5 Is a Critical Intermediate of Costimulatory Signaling Pathways Triggered by Glucocorticoid-induced TNFR in T Cells.
- Author
-
Esparza, Edward M., Lindsten, Tullia, Stockhausen, Julia M., and Arch, Robert H.
- Subjects
- *
TUMOR necrosis factors , *GLUCOCORTICOIDS , *T cells , *CELL differentiation , *IMMUNE response , *MITOGEN-activated protein kinases - Abstract
Tumor necrosis factor receptor (TNFR) family members such as glucocorticoid-induced TNFR (GITR) control T cell activation, differentiation, and effector functions. Importantly, GITR functions as a pivotal regulator of physiologic and pathologic immune responses by abrogating the suppressive effects of T regulatory cells and costimulating T effector cells. However, the molecular mechanisms underlying GITR-triggered signal transduction pathways remain unclear. Interestingly, GITR-induced stimulation of TNFR-associated factor (TRAF) 5-deficient T cells resulted in decreased activation of nuclear factor κB as well as the mitogen-activated protein kinases p38 and extracellular signal-regulated protein kinase, whereas activation of c-Jun N-terminal kinase was less affected. Consistent with impaired signaling, costimulatory effects of GITR were diminished in TRAF5-/- T cells. In sum, our studies indicate that TRAF5 plays a crucial role in GITR- induced signaling pathways that augment T cell activation. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
10. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
- Author
-
Yoshida S, Ikenaga N, Liu SB, Peng ZW, Chung J, Sverdlov DY, Miyamoto M, Kim YO, Ogawa S, Arch RH, Schuppan D, and Popov Y
- Subjects
- ATP Binding Cassette Transporter, Subfamily B genetics, Adult, Aged, Aged, 80 and over, Animals, Antibodies, Monoclonal pharmacology, Antibodies, Neutralizing pharmacology, Aspirin pharmacology, Blood Platelets drug effects, Blood Platelets immunology, Disease Models, Animal, Female, Humans, Liver Cirrhosis drug therapy, Liver Cirrhosis pathology, Male, Mice, Inbred C57BL, Mice, Knockout, Middle Aged, Platelet Aggregation Inhibitors pharmacology, Proto-Oncogene Proteins c-sis genetics, Proto-Oncogene Proteins c-sis immunology, RNA, Messenger metabolism, ATP-Binding Cassette Sub-Family B Member 4, Bile Ducts, Extrahepatic metabolism, Blood Platelets metabolism, Hepatic Stellate Cells metabolism, Liver Cirrhosis metabolism, Proto-Oncogene Proteins c-sis metabolism
- Abstract
Background & Aims: Platelet-derived growth factor-β (PDGFB) is a mitogen for hepatic stellate cells (HSCs). We studied the cellular sources of PDGFB and the effects of a high-affinity monoclonal antibody against PDGFB (MOR8457) in mouse models of biliary fibrosis., Methods: Cellular sources of PDGFB were identified using quantitative reverse-transcription polymerase chain reaction, biochemical, and immunohistologic methods. Mice with advanced biliary fibrosis, MDR2(Abcb4)-null mice, and C57Bl/6 (control) mice were placed on 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-supplemented diets and were given weekly intraperitoneal injections of MOR8457. Platelets were depleted from MDR2-null mice by injection of an antibody against CD41, or inhibited with diets containing low-dose aspirin. Liver tissues were collected and analyzed by quantitative reverse-transcription PCR and histologic and biochemical analyses., Results: Levels of PDGFB protein, but not messenger RNA, were increased in fibrotic livers of MDR2-null mice, compared with control mice. Platelet clusters were detected in the hepatic endothelium, in close proximity to HSCs, and were identified as a source of PDGFB protein in MDR2-null mice. Levels of the PDGFB were increased in serum samples from patients with early stages of liver fibrosis of various etiologies (F1-2, n = 16; P < .05), compared with nonfibrotic liver tissue (F0, n = 12). Depletion of platelets from MDR2-null mice normalized hepatic levels of PDGFB within 48 hours, reducing levels of a marker of HSC activation (α-smooth muscle actin) and expression of genes that promote fibrosis. Diets supplemented with low-dose aspirin reduced circulating serum and hepatic levels of PDGFB and significantly reduced progression of fibrosis in MDR2-null mice over 1 year. MOR8457 produced a dose-dependent decrease in liver fibrosis in MDR2-null mice, reducing collagen deposition by 45% and expression of fibrosis-associated genes by 50%, compared with mice given a control antibody. In vitro, platelets activated freshly isolated HSCs (induction of α-smooth muscle actin and fibrosis-associated genes) via a PDGFB-dependent mechanism. MOR8457 also reduced liver fibrosis in mice placed on DDC-supplemented diets., Conclusions: Platelets produce PDGFB to activate HSC and promote fibrosis in MDR2-null mice and mice on DDC-supplemented diets. Antiplatelet therapy or selective inhibition of PDGFB might reduce biliary fibrosis in patients with liver disease., (Copyright © 2014 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
11. Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: regulation at the interface between regulatory T cells and immune effector cells.
- Author
-
Esparza EM and Arch RH
- Subjects
- Animals, Antigens, CD, Antigens, Differentiation metabolism, Autoimmune Diseases immunology, B-Lymphocytes metabolism, CTLA-4 Antigen, Forkhead Transcription Factors metabolism, Glucocorticoid-Induced TNFR-Related Protein, Glucocorticoids metabolism, Humans, Immune System, Inflammation, Interleukin-2 metabolism, Models, Biological, NF-kappa B metabolism, Receptors, Nerve Growth Factor metabolism, Receptors, Tumor Necrosis Factor metabolism, T-Lymphocytes metabolism, Transcription, Genetic, Signal Transduction, T-Lymphocytes, Regulatory metabolism, Tumor Necrosis Factor-alpha metabolism
- Abstract
Mammals and other higher vertebrates have developed an adaptive immune system to defy effectively countless pathogens and cancerous cells encountered during the lifetime of an individual. B and T lymphocytes, which are essential in orchestrating adaptive immune responses, express surface receptors specific for foreign and abnormal self-antigens. Genesis of this antigen receptor repertoire poses significant risks for autoimmunity caused by self-reactive lymphocytes. Therefore, organisms with adaptive immune systems have evolved central and peripheral tolerance mechanisms. In peripheral tissues, regulatory T (Treg) cells function in a dominant, cell-extrinsic manner to limit inflammatory responses and autoimmune disorders. To tap the potential clinical utility of these specialized lymphocytes, advances have been made in understanding how Treg cell-mediated suppression of immune effector cells is achieved and regulated. Importantly, signaling induced by a recently identified member of the tumor necrosis factor receptor (TNFR) family, termed glucocorticoid-induced TNFR family-related gene (GITR), abrogates the suppressive effects of Treg cells. GITR plays a pivotal role in controlling T cell-mediated responses in experimental models of organ-specific autoimmunity, chronic infection, and anti-tumor immunity. These findings highlight the importance of elucidating the molecular underpinnings of GITR-induced signaling. We propose that GITR employs adapter proteins, including TNFR-associated factors (TRAFs), to regulate diverse signaling pathways and transcriptional programs that control the interplay between Treg cells and immune effector cells.
- Published
- 2006
- Full Text
- View/download PDF
12. Glucocorticoid-induced TNF receptor, a costimulatory receptor on naive and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-kappa B activation.
- Author
-
Esparza EM and Arch RH
- Subjects
- Amino Acid Sequence, Animals, Carrier Proteins physiology, Cell Line, Conserved Sequence, Cysteine Endopeptidases, Cytoplasm chemistry, Cytoplasm metabolism, DNA-Binding Proteins, Down-Regulation genetics, Glucocorticoid-Induced TNFR-Related Protein, Humans, Hydrogen-Ion Concentration, Intracellular Signaling Peptides and Proteins, Lymphocyte Activation genetics, Mice, Mice, Transgenic, Molecular Sequence Data, Nuclear Proteins, Protein Structure, Tertiary genetics, Protein Transport genetics, Protein Transport immunology, Proteins pharmacology, Receptors, Nerve Growth Factor antagonists & inhibitors, Receptors, Nerve Growth Factor metabolism, Receptors, Tumor Necrosis Factor antagonists & inhibitors, Receptors, Tumor Necrosis Factor metabolism, Resting Phase, Cell Cycle genetics, TNF Receptor-Associated Factor 2 metabolism, Transfection, Tumor Necrosis Factor alpha-Induced Protein 3, Tumor Necrosis Factors, Down-Regulation immunology, Lymphocyte Activation immunology, NF-kappa B antagonists & inhibitors, NF-kappa B metabolism, Receptors, Nerve Growth Factor physiology, Receptors, Tumor Necrosis Factor physiology, Resting Phase, Cell Cycle immunology, TNF Receptor-Associated Factor 2 physiology
- Abstract
Glucocorticoid-induced TNFR (GITR) has been implicated as an essential regulator of immune responses to self tissues and pathogens. We have recently shown that GITR-induced cellular events promote survival of naive T cells, but are insufficient to protect against activation-induced cell death. However, the molecular mechanisms of GITR-induced signal transduction that influence physiologic and pathologic immune responses are not well understood. TNFR-associated factors (TRAFs) are pivotal adapter proteins involved in signal transduction pathways of TNFR-related proteins. Yeast two-hybrid assays and studies in HEK293 cells and primary lymphocytes indicated interactions between TRAF2 and GITR mediated by acidic residues in the cytoplasmic domain of the receptor. GITR-induced activation of NF-kappaB is blocked by A20, an NF-kappaB-inducible protein that interacts with TRAFs and functions in a negative feedback mechanism downstream of other TNFRs. Interestingly, in contrast with its effects on signaling triggered by other TNFRs, our functional studies revealed that TRAF2 plays a novel inhibitory role in GITR-triggered NF-kappaB activation.
- Published
- 2005
- Full Text
- View/download PDF
13. Glucocorticoid-induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation.
- Author
-
Esparza EM and Arch RH
- Subjects
- Animals, Carrier Proteins metabolism, Cell Death immunology, Cell Proliferation, Cell Survival immunology, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 biosynthesis, Ligands, Mice, Mice, Inbred BALB C, Mice, Transgenic, Mitogen-Activated Protein Kinases metabolism, Mitogen-Activated Protein Kinases physiology, NF-kappa B metabolism, NF-kappa B physiology, Receptors, Nerve Growth Factor metabolism, Receptors, Tumor Necrosis Factor metabolism, Resting Phase, Cell Cycle immunology, T-Lymphocytes enzymology, T-Lymphocytes immunology, Tumor Necrosis Factors, Lymphocyte Activation immunology, Receptors, Nerve Growth Factor physiology, Receptors, Tumor Necrosis Factor physiology, T-Lymphocytes cytology, T-Lymphocytes metabolism
- Abstract
Glucocorticoid-induced TNFR (GITR) is a member of the TNFR family that can inhibit the suppressive function of regulatory T cells and promote the survival and activation of T cells. However, little is known about the molecular mechanisms regulating T cell survival and activation downstream of GITR. To gain further insight into the cellular events and signaling pathways triggered by GITR, survival, proliferation, and cytokine production as well as activation of MAPKs and NF-kappaB were monitored after cross-linking of the receptor on naive and activated T cells. GITR cross-linking provided costimulation of naive and activated T cells and resulted in activation of MAPKs and NF-kappaB. Although GITR-induced signaling pathways augmented the survival of naive T cells, they were not sufficient to inhibit activation-induced cell death triggered by CD3 cross-linking of activated T cells. Differences in the contributions of GITR to cell survival between naive and activated T cells suggest that the receptor triggers specific pathways depending on the activation state of the T cell.
- Published
- 2005
- Full Text
- View/download PDF
14. A chemotactic peptide from laminin alpha 5 functions as a regulator of inflammatory immune responses via TNF alpha-mediated signaling.
- Author
-
Adair-Kirk TL, Atkinson JJ, Kelley DG, Arch RH, Miner JH, and Senior RM
- Subjects
- Amino Acid Sequence, Animals, Cell Line, Gene Expression Regulation immunology, Humans, Macrophages, Peritoneal enzymology, Macrophages, Peritoneal immunology, Macrophages, Peritoneal metabolism, Matrix Metalloproteinase 9 biosynthesis, Mice, Mice, Inbred C57BL, Mice, Knockout, Molecular Sequence Data, Monocytes immunology, Monocytes metabolism, Neutrophil Infiltration genetics, Neutrophil Infiltration immunology, Oligonucleotide Array Sequence Analysis, Receptors, Tumor Necrosis Factor, Type I biosynthesis, Receptors, Tumor Necrosis Factor, Type I deficiency, Receptors, Tumor Necrosis Factor, Type I genetics, Receptors, Tumor Necrosis Factor, Type II biosynthesis, Receptors, Tumor Necrosis Factor, Type II deficiency, Receptors, Tumor Necrosis Factor, Type II genetics, Signal Transduction genetics, Tumor Necrosis Factor-alpha biosynthesis, Tumor Necrosis Factor-alpha genetics, Chemotactic Factors physiology, Inflammation Mediators physiology, Laminin physiology, Peptide Fragments physiology, Signal Transduction immunology, Tumor Necrosis Factor-alpha physiology
- Abstract
Tissue injury triggers inflammatory responses that may result in release of degradation products or exposure of cryptic domains of extracellular matrix components. Previously, we have shown that a cryptic peptide (AQARSAASKVKVSMKF) in the alpha-chain of laminin-10 (alpha5beta1gamma1), a prominent basement membrane component, is chemotactic for both neutrophils (PMNs) and macrophages (Mphis) and induces matrix metalloproteinase-9 (MMP-9) production. To determine whether AQARSAASKVKVSMKF has additional effects on inflammatory cells, we performed microarray analysis of RNA from RAW264.7 Mphis stimulated with AQARSAASKVKVSMKF. Several cytokines and cytokine receptors were increased >3-fold in response to the laminin alpha5 peptide. Among these were TNF-alpha and one of its receptors, the p75 TNFR (TNFR-II), increasing 3.5- and 5.7-fold, respectively. However, the peptide had no effect on p55 TNFR (TNFR-I) expression. Corroborating the microarray data, the protein levels of TNF-alpha and TNFR-II were increased following stimulation of RAW264.7 cells with AQARSAASKVKVSMKF. In addition, we determined that the production of TNF-alpha and TNFR-II in response to AQARSAASKVKVSMKF preceded the production of MMP-9. Furthermore, using primary Mphis from mice deficient in TNFR-I, TNFR-II, or both TNF-alpha receptors (TNFRs), we determined that AQARSAASKVKVSMKF induces MMP-9 expression by Mphis through a pathway triggered by TNFR-II. However, TNF-alpha signaling is not required for AQARSAASKVKVSMKF-induced PMN release of MMP-9 or PMN emigration. These data suggest that interactions of inflammatory cells with basement membrane components may orchestrate immune responses by inducing expression of cytokines, recruitment of inflammatory cells, and release of proteinases.
- Published
- 2005
- Full Text
- View/download PDF
15. Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms.
- Author
-
Toennies HM, Green JM, and Arch RH
- Subjects
- Animals, Cell Differentiation, Interleukin-4 pharmacology, Ki-1 Antigen analysis, Lymphocyte Activation, Mice, Mice, Inbred Strains, Receptors, OX40, Receptors, Tumor Necrosis Factor analysis, STAT6 Transcription Factor, Signal Transduction, Trans-Activators physiology, Gene Expression Regulation, Ki-1 Antigen biosynthesis, Receptors, Tumor Necrosis Factor biosynthesis, T-Lymphocyte Subsets metabolism
- Abstract
Members of the TNF receptor (TNFR) superfamily are cell-surface proteins that can be found on most cell types including lymphocytes. Although some TNFR-related molecules are constitutively expressed, others, such as CD30 and Ox40, are induced upon activation of lymphocytes. CD30 and Ox40 are predominantly expressed on activated T helper (T(h))2 cells. Both receptors can activate c-Jun N-terminal kinase (JNK) and nuclear factor-kappaB (NF-kappaB) and have been suggested to play costimulatory roles in lymphocyte activation. To gain further insight into events triggered by both TNFR-related molecules, a detailed analysis of their expression patterns has been performed. We found that CD30 and Ox40 were coexpressed on T(h)2 cells. However, in contrast to CD30, Ox40 was also expressed on T(h)1 cells. Although expression of both receptors is augmented by interleukin-4, only CD30 expression is dependent on signal transducer and activator of transcription (STAT)-6-mediated signaling. Differences in the regulatory pathways controlling expression of CD30 and Ox40 suggest distinct, functional effects triggered by the two TNFR-related molecules during lymphocyte activation.
- Published
- 2004
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.